The European Society for Medical Oncology (ESMO) has expressed concern that the proposed EU General Data Protection Regulation could make cancer research impossible and add a significant burden to both doctors and cancer patients.
Health officials say that the head of the government lab which potentially exposed workers to...
The same federal scientist who recently found forgotten samples of smallpox at a federal lab...
Food companies and restaurants could soon face government pressure to make their foods less salty — a long-awaited federal effort to try to prevent thousands of deaths each year from heart disease and stroke. The Food and Drug Administration is preparing to issue voluntary guidelines asking the food industry to lower sodium levels.
Ten projects that will enable non-government researchers to conduct clinical research at the National Institutes of Health’s Clinical Center in Bethesda, Md. were announced. Through these three-year, renewable awards of up to $500,000 per year, scientists from institutions across the United States will collaborate with government scientists in a highly specialized hospital setting.
In December 2013, the U.S. Food and Drug Administration approved the first high-throughput DNA sequencer. Helping get the new device approved was another first: the initial use of a reference set of standard genotypes, or "coded blueprints" of a person's genetic traits.
The U.S. and 26 other nations are announcing a new collaboration to prevent and fight outbreaks of dangerous infectious diseases before they spread around the globe. U.S. health officials say the Global Health Security Agenda is a priority because there are too many blind spots — countries that lack the health care necessary to sound the alarm when a new infection emerges.
Getting in the right shape might be just as important in a biology lab as a gym. Shape is thought to play an important role in the effectiveness of cells grown to repair or replace damaged tissue in the body. To help design new structures that enable cells to "shape up," researchers at the NIST have come up with a way to measure, and more importantly, classify, the shapes cells tend to take in different environments.
The United States' predominance in science and technology eroded further during the last decade, as several Asian nations—particularly China and South Korea—increased their innovation capacities. According to a report released by the National Science Board, the major Asian economies, taken together, now perform a larger share of global R&D than the U.S.
Broader global access to lifesaving antiretroviral therapies and wider implementation of proven HIV prevention strategies could potentially control and perhaps end the HIV/AIDS pandemic. However, a safe and at least moderately effective HIV vaccine is needed to reach this goal more expeditiously and in a more sustainable way, according to a new commentary from Anthony S. Fauci, MD, director of the NIAID.
The National Institutes of Health, 10 biopharmaceutical companies and several nonprofit organizations today launched an unprecedented partnership to transform the current model for identifying and validating the most promising biological targets of disease for new diagnostics and drug development.
Researchers at the National Institute of Standards and Technology (NIST) and in Lithuania have used a NIST-developed laboratory model of a simplified cell membrane to accurately detect and measure a protein associated with a serious gynecological disease, bacterial vaginosis (BV), at extraordinarily low concentrations.
The partial model for Obamacare—Massachusetts’ near-universal health care program, adopted in 2006—resulted in measurably improved health. According to a study conducted by researchers from Harvard University and the University of Michigan—with help from the Centers for Disease Control (CDC)—the health of Massachusetts residents rose more in the first five years of the program than did the health of residents in other New England states.
Thermo Fisher Scientific announced that it has signed an agreement to sell its cell culture (sera and media), gene modulation and magnetic beads businesses to GE Healthcare, a unit of General Electric Company, for approximately $1.06 billion.
The Food and Drug Administration approved 27 first-of-a-kind drugs in 2013, down from 39 new medications in 2012, which was a 15-year high.
23andMe, the consumer genetics company halted by the FDA for ignoring repeated questions, is being conciliatory. The company offered raw gene data, and interpretative reports, to the general public on more than 240 diseases and traits until Dec. 5, when it announced it would cease taking new customers as a result of FDA action. However: “the company is now writing conciliatory letters to regulators,” says an insider.
The federal government said Monday it has no evidence that antibacterial chemicals used in liquid soaps and washes help prevent the spread of germs, and it is reviewing research suggesting they may pose health risks.
Citing a potential threat to public health, the Food and Drug Administration is taking steps toward phasing out the use of some antibiotics in animals processed for meat.
Genetic testing company 23andMe Inc. will comply with a Food and Drug Administration directive to stop selling health-related genetic tests during a regulatory review. The company said late Thursday that it will continue to provide ancestry-related information to customers and raw genetic data without interpretation.
The 1984 National Organ Transplantation Act that set the payment ban didn't just refer to solid organs — it included bone marrow transplants, too. Now, the government now has proposed a regulation to keep the ban intact by rewriting some legal definitions to clarify that it covers marrow-producing stem cells.
The Food and Drug Administration has ordered Google-backed genetic test maker 23andMe to halt sales of its personalized DNA test kits, saying the company has failed to show that the technology is supported by science.
The U.S. Food and Drug Administration allowed marketing of four diagnostic devices that can be used for high throughput gene sequencing, often referred to as “next generation sequencing” (NGS). These instruments, reagents and test systems allow labs to sequence a patient’s DNA.
The U.S. Food and Drug Administration today approved a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications.
President Obama’s famous BRAIN mapping initiative is only 15%-of-a-brain initiative, said top NIH neuroscientist Douglas Fields and a growing chorus of others recently. The reason: while 85% of the brain is made of glial cells, stunningly, no governmental BRAIN publications, until recently, mentioned the word.
The National Institutes of Health announced it will award $17 million this year for 24 research projects designed to improve scientists’ understanding of a newly discovered type of cell-to-cell communication based on extracellular (outside the cell) RNA, also called exRNA.
As the U.S. Food and Drug Administration (FDA) continues to finalize regulations to establish a pathway for approving biopharmaceutical or biosimilar drugs, leading branded drug manufacturers are looking ahead and lobbying state legislatures to enact laws that would limit the substitution of biogenerics for brand-name drugs.
Humans don't "own" their own genes, the cellular chemicals that define who they are and what diseases they might be at risk for. Through more than 40,000 patents on DNA molecules, companies have essentially claimed the entire human genome for profit.